These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7733526)

  • 1. [Value of octreotide in the treatment of postoperative enterocutaneous fistula].
    Sleth JC; Andraos Y; Borie F; Dumay R; Legroux P
    Ann Fr Anesth Reanim; 1994; 13(5):738-40. PubMed ID: 7733526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
    Alivizatos V; Felekis D; Zorbalas A
    Hepatogastroenterology; 2002; 49(46):1010-2. PubMed ID: 12143189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995.
    Nubiola P; Badia JM; Martinez-Rodenas F; Gil MJ; Segura M; Sancho J; Sitges-Serra A
    Ann Surg; 1989 Jul; 210(1):56-8. PubMed ID: 2500900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog.
    Kocak S; Bumin C; Karayalcin K; Alacayir I; Aribal D
    Dig Dis; 1994; 12(1):62-8. PubMed ID: 8200125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of gastrointestinal fistulas with Sandostatin.
    Sitges-Serra A; Guirao X; Pereira JA; Nubiola P
    Digestion; 1993; 54 Suppl 1():38-40. PubMed ID: 8359567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
    Sancho JJ; di Costanzo J; Nubiola P; Larrad A; Beguiristain A; Roqueta F; Franch G; Oliva A; Gubern JM; Sitges-Serra A
    Br J Surg; 1995 May; 82(5):638-41. PubMed ID: 7613936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition].
    Hernández-Aranda JC; Gallo-Chico B; Flores-Ramírez LA; Avalos-Huante R; Magos-Vázquez FJ; Ramírez-Barba EJ
    Nutr Hosp; 1996; 11(4):226-9. PubMed ID: 8962902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.
    Scott NA; Finnegan S; Irving MH
    Acta Gastroenterol Belg; 1993; 56(3-4):266-70. PubMed ID: 8266769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Post-nephrectomy duodeno-cutaneous fistula resolved with parenteral nutrition and octreotide (somatostatin analogue)].
    Batista Miranda JE; Solé Balcells FJ; Peñalba F; Mayoral J
    Arch Esp Urol; 1994 Oct; 47(8):810-2. PubMed ID: 7818305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide for treatment of postoperative alimentary tract fistulas.
    Paran H; Neufeld D; Kaplan O; Klausner J; Freund U
    World J Surg; 1995; 19(3):430-3; discussion 433-4. PubMed ID: 7639001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding.
    Chen RJ; Fang JF; Chen MF
    Am J Gastroenterol; 1992 Sep; 87(9):1212-5. PubMed ID: 1519586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterocutaneous fistula: are treatments improving?
    Draus JM; Huss SA; Harty NJ; Cheadle WG; Larson GM
    Surgery; 2006 Oct; 140(4):570-6; discussion 576-8. PubMed ID: 17011904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complicated enterocutaneous fistulas: failure of octreotide to improve healing.
    Alvarez C; McFadden DW; Reber HA
    World J Surg; 2000 May; 24(5):533-7; discussion 538. PubMed ID: 10787072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of somatostatin analogues in the management of enterocutaneous fistulae.
    Jamil M; Ahmed U; Sobia H
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):237-40. PubMed ID: 15228830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of a high-output postoperative enterocutaneous fistula with a vacuum sealing method and continuous enteral nutrition.
    Hyon SH; Martinez-Garbino JA; Benati ML; Lopez-Avellaneda ME; Brozzi NA; Argibay PF
    ASAIO J; 2000; 46(4):511-4. PubMed ID: 10926156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fistulas of the gastrointestinal tract with total parenteral nutrition and octreotide in patients with carcinoma.
    Spiliotis J; Briand D; Gouttebel MC; Astre C; Louer B; Saint-Aubert B; Kalfarentzos F; Androulakis J; Joyeux H
    Surg Gynecol Obstet; 1993 Jun; 176(6):575-80. PubMed ID: 8322132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide for enterocutaneous fistulas of Crohn's disease.
    Lavy A; Yasin K
    Can J Gastroenterol; 2003 Sep; 17(9):555-8. PubMed ID: 14532930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of small intestinal fistulas with octreotide, a somatostatin analog.
    Boike GM; Sightler SE; Averette HE
    J Surg Oncol; 1992 Jan; 49(1):63-5. PubMed ID: 1548884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output.
    Nubiola-Calonge P; Badía JM; Sancho J; Gil MJ; Segura M; Sitges-Serra A
    Lancet; 1987 Sep; 2(8560):672-4. PubMed ID: 2887951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.